Company: DMAAR
Filing Date: 2025-11-17
Form Type: NT 10-Q
Source: 0001213900-25-111208
Chunk: 0

Company: Drugs Made In America Acquisition Corp.
Filing Date: 2025-11-17
Form: NT 10-Q
Chunk 0
---
<div align='center'>UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 12b-25</div>

|           | NOTIFICATION OF LATE FILING | SEC FILE NUMBER |
| 001-42467 |                             |                 |
|           |                             | CUSIP NUMBER    |
|           |                             | G2847J 104      |

| (Check One): | ☐ Form 10-K  | ☐ Form 20-F | ☐ Form 11-K | ☒ Form 10-Q | ☐ Form 10-D | ☐ Form N-CEN |
|              | ☐ Form N-CSR |             |             |             |             |              |

For Period Ended: September 30, 2025

| ☐ | Transition Report on Form 10-K |
| ☐ | Transition Report on Form 20-F |
| ☐ | Transition Report on Form 11-K |
| ☐ | Transition Report on Form 10-Q |

For the Transition Period Ended: _______________

| Read Instruction (on back page) Before Preparing                   
 Form. Please Print or Type.                                        
 Nothing in this form shall be construed to imply                   
 that the Commission has verified any information contained herein. |

If the notification relates to a portion of the
filing checked above, identify the Item(s) to which the notification relates:

PART I – REGISTRANT INFORMATION

Drugs Made In America Acquisition Corp.

Full Name of Registrant

Former Name if Applicable

1 East Broward Boulevard, Suite 700

Address of Principal Executive Office (Street and Number)

Fort Lauderdale, FL 33301

City, State and Zip Code

PART II – RULES 12b-25(b) AND (c)

If the subject report could not be filed without
unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box
if appropriate)

|   | -a | The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;                                                                                                                                                                                                                                                                                                                                    |
| ☒ | -b | The subject annual report, semi-annual report, transition report on Form10-K, Form 20-F, Form 11-K, Form N-CEN or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or